Literature DB >> 25304423

[Morphological diagnostics of malignant pleural mesothelioma].

K Junker1, K-M Müller.   

Abstract

The World Health Organization (WHO) classification differentiates between pleural tumors of mesothelial and mesenchymal origin as well as lymphoproliferative disorders, with malignant mesotheliomas forming the most common pleural primary tumor. Histologically, epithelioid (40-60 %), sarcomatoid (20-40 %), and biphasic mesotheliomas (20-40 %) are distinguished. The certain morphological diagnosis of a malignant pleural mesothelioma requires the establishment of mesothelial differentiation by means of an appropriate panel of antibodies to exclude pleural dissemination of a pulmonary or extrapulmonary epithelial malignancy and also requires the establishment of at least focal invasive growth to distinguish from reactive mesothelial proliferation. The exclusion of a malignant pleural mesothelioma may induce further differential diagnostic considerations, e. g. concerning the assignment to a certain primary tumor after the establishment of carcinomatous pleuritis.

Entities:  

Mesh:

Year:  2014        PMID: 25304423     DOI: 10.1007/s00292-014-1921-3

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  12 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

2.  [Differential diagnosis of preneoplastic lesions of the pleura and of early mesothelioma: immunohistochemical and morphological findings].

Authors:  M Krismann; P Thattamparambil; F Simon; G Johnen
Journal:  Pathologe       Date:  2006-03       Impact factor: 1.011

3.  Severe chromosomal aberrations in pleural mesotheliomas with unusual mesodermal features. Comparative genomic hybridization evidence for a mesothelioma subgroup.

Authors:  M Krismann; K M Müller; M Jaworska; G Johnen
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

4.  The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.

Authors:  J T Hodgson; A Darnton
Journal:  Ann Occup Hyg       Date:  2000-12

5.  Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Marc de Perrot; Karl Uy; Masaki Anraku; Ming S Tsao; Gail Darling; Thomas K Waddell; Andrew F Pierre; Andrea Bezjak; Shaf Keshavjee; Michael R Johnston
Journal:  J Thorac Cardiovasc Surg       Date:  2007-01       Impact factor: 5.209

6.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies.

Authors:  R Peto; S Darby; H Deo; P Silcocks; E Whitley; R Doll
Journal:  BMJ       Date:  2000-08-05

7.  Malignant mesothelioma in Australia, 1945-2000.

Authors:  James Leigh; Patricia Davidson; Leigh Hendrie; Dale Berry
Journal:  Am J Ind Med       Date:  2002-03       Impact factor: 2.214

Review 8.  Epidemiology of mesothelioma and historical background.

Authors:  J E Craighead
Journal:  Recent Results Cancer Res       Date:  2011

Review 9.  Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.

Authors:  Nelson G Ordóñez
Journal:  Hum Pathol       Date:  2012-09-07       Impact factor: 3.466

Review 10.  Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health.

Authors:  Volker Neumann; Stefan Löseke; Dennis Nowak; Felix J F Herth; Andrea Tannapfel
Journal:  Dtsch Arztebl Int       Date:  2013-05-03       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.